SEOUL, Jan. 6 (Korea Bizwire) — South Korean biotech company GC Pharma said Wednesday it has completed phase two clinical trials of its plasma therapy treatment for the novel coronavirus. The plasma therapy, known as GC5131A, is a type of hyperimmune globulin drug that uses blood plasma taken from people who have fully recovered from [...]
SEOUL, Nov. 3 (Korea Bizwire) — South Korean biotech company GC Pharma has begun additional production of its plasma therapy treatment for the novel coronavirus amid growing demand for treatment purposes, company officials said Tuesday. The plasma therapy, known as GC5131, is a type of hyperimmune globulin drug that uses blood plasma taken from people [...]
SEOUL, Sept. 21 (Korea Bizwire) — South Korea’s biotech company GC Pharma will soon begin advanced clinical trials of its plasma therapy treatment for the novel coronavirus both locally and globally, company officials said Monday. The plasma therapy, known as GC5131, is a type of hyperimmune globulin drug that uses blood plasma taken from people [...]
SEOUL, Feb. 21 (Korea Bizwire) – Yuhan Corporation, GC Pharma, and Kwang Dong Pharmaceutical are expected to hold the top three positions in the South Korean pharmaceutical industry this year, with their latest sales figures exceeding 1 trillion won. Both Yuhan and GC Pharma are on course to join the ‘one trillion club’ again this year, [...]